Metraipolis › archive › dc_455ffc25e433

Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine — Europe PMC PMID:41646968

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41646968
DOI
10.3389/fimmu.2025.1706958
License (as archived)
solo-consultazione
Archived
2026-11-06T15:21:50.696Z
SHA-256 of the archived text
cda551aa134c5d2720fcbba84a3972c58aeb30b7bcb29534c21cbee48fba1695
Stable URL of this page
https://metraipolis.com/documento/dc_455ffc25e433

How to cite

Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine — Europe PMC PMID:41646968 — Europe PMC (en), https://europepmc.org/article/MED/41646968 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_455ffc25e433 (Metraipolis archive dc_455ffc25e433, sha256 cda551aa134c5d2720fcbba84a3972c58aeb30b7bcb29534c21cbee48fba1695)
BibTeX
@misc{dc455ffc25e433,
  title = {Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine — Europe PMC PMID:41646968},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646968},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_455ffc25e433; sha256 cda551aa134c5d2720fcbba84a3972c58aeb30b7bcb29534c21cbee48fba1695},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646968. Agents can read the archived copy with the MCP tool read_document.